Biotech Turns to On-Premise AI

KALA BIO is pivoting from a clinical-stage biopharmaceutical company to also become an AI infrastructure partner for the biotech industry. This strategic shift comes as the company's stock has fallen nearly 95% over the past year, with a current market capitalization of just $9.91 million. The company has secured an exclusive worldwide license for the "Researgency" AI platform from Younet AI. The deal involves up to $530,000 in initial cash payments and the issuance of 5 million KALA common shares to Younet AI, with an option for KALA to acquire Younet for $55 million. The on-premises model directly challenges the dominant cloud-based approach for AI in biotech. Many organizations are hesitant to upload proprietary biological data and trade secrets to centralized third-party cloud platforms, creating a market opportunity for a secure, data-sovereign solution. KALA's platform will be deployed directly on a client's own servers, ensuring that sensitive intellectual property never leaves their control. KALA will first validate the platform internally by applying it to its own mesenchymal stem cell secretome (MSC-S) datasets and its KPI-012 clinical program. Following this internal validation, the company plans to license the platform to other biotech and pharmaceutical companies through a recurring subscription model. The platform's AI agents are designed for specific biomedical research functions, such as analyzing protein interactions, reviewing drug safety literature, and modeling clinical trial outcomes. This addresses a significant market where the top 20 pharmaceutical companies invested approximately $167 billion in R&D in 2024. This move toward on-premise "AI factories" reflects a broader industry trend. Eli Lilly recently launched the world's first NVIDIA DGX SuperPOD powered by B300 systems for in-house drug discovery. The Health Insurance Portability and Accountability Act (HIPAA) mandates strict security, auditing, and encryption for patient data, creating significant compliance challenges for cloud-based AI, where the average healthcare data breach costs over $9 million.